Lunai Bioworks (LNAI) Asset Utilization Ratio (2016 - 2026)

Lunai Bioworks (LNAI) recorded quarterly Asset Utilization Ratio of 0.01 in Q1 2026, down 90.65% quarter-over-quarter from 0.07 in Q2 2016.

Lunai Bioworks (LNAI) Asset Utilization Ratio (2016 - 2026) Analysis & Trends

Lunai Bioworks' Asset Utilization Ratio history runs 2 years deep, the most recent figure standing at 0.01 for Q1 2026.

In Q1 2026, Asset Utilization Ratio changed N/A year-over-year to 0.01; the TTM figure through Mar 2026 stood at 0.01 (changed N/A YoY), while the FY2016 annual figure was 0.04, changed N/A from the prior year.
Asset Utilization Ratio was 0.01 for Q1 2026 at Lunai Bioworks, down from 0.07 in the prior quarter.
In the past five years, Asset Utilization Ratio ranged from a high of 0.01 in Q1 2026 to a low of 0.01 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	0.55
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	0.60
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	1,422.00
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	0.47
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Lunai Bioworks	95.85 Mn	92.70 Mn	20,942.00	0.01

Download Data

Date	Value
Mar 31, 2026	0.01
Jun 30, 2016	0.07